IIM
CGEM icon

INTECH Investment Management’s Cullinan Oncology CGEM Stock Holding History

INTECH Investment Management’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$226K Sell
12,418
-2,495
-17% -$37K ﹤0.01% 1731
2026
Q1 		$212K Sell
14,913
-13,024
-47% -$167K ﹤0.01% 1730
2025
Q4 		$289K Buy
27,937
+32
+0.1% +$289 ﹤0.01% 1779
2025
Q3 		$165K Sell
27,905
-9,467
-25% -$69.3K ﹤0.01% 2132
2025
Q2 		$281K Sell
37,372
-12,506
-25% -$100K ﹤0.01% 1902
2025
Q1 		$378K Buy
49,878
+18,096
+57% +$174K ﹤0.01% 1765
2024
Q4 		$387K Buy
31,782
+14,295
+82% +$205K ﹤0.01% 1707
2024
Q3 		$293K Buy
+17,487
New +$310K ﹤0.01% 1536

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

INTECH Investment Management's CGEM Position: Q2 2026 in Review

INTECH Investment Management reduced its Cullinan Oncology (CGEM) stake by 17% in Q2 2026, selling an estimated $37K and leaving 12,418 shares worth $226K. The position accounts for ﹤0.01% of the portfolio, ranked #1731.

INTECH Investment Management first reported a position in CGEM in Q3 2024 and has held it in 8 quarters since. The position peaked at $387K in Q4 2024. 183 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • INTECH Investment Management held 12,418 shares of Cullinan Oncology worth $226K as of Q2 2026.
  • INTECH Investment Management sold 2,495 Cullinan Oncology shares in Q2 2026, an estimated $37K.
  • Cullinan Oncology made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1731 holding.
  • INTECH Investment Management first reported a position in Cullinan Oncology in Q3 2024 and has held it in 8 quarters since.
  • INTECH Investment Management's Cullinan Oncology position peaked at $387K in Q4 2024.
  • 183 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.